Kodiak Sciences KOD
NASDAQ KOD
$35.74 -0.62 (-1.71%)
As of: Sep 4, 2026 · 3:22 PM EDT

Kodiak Sciences (KOD) Selling, General & Administrative (2017 - 2026)

Analysis

Kodiak Sciences (KOD) Selling, General & Administrative (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -417.00 Mn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 216.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - 110.21 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 593.21 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 347.92 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 161.89 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 247.47 Mn
10 Kodiak Sciences 2.23 Bn 2.23 Bn - 10.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.76 Mn
Mar 31, 2026 11.23 Mn
Dec 31, 2025 11.96 Mn
Sep 30, 2025 11.88 Mn
Jun 30, 2025 12.75 Mn
Mar 31, 2025 15.43 Mn
Dec 31, 2024 14.41 Mn
Sep 30, 2024 14.75 Mn
Jun 30, 2024 15.47 Mn
Mar 31, 2024 16.12 Mn
Dec 31, 2023 16.75 Mn
Sep 30, 2023 18.31 Mn
Jun 30, 2023 17.87 Mn
Mar 31, 2023 18.10 Mn
Dec 31, 2022 18.07 Mn
Sep 30, 2022 17.80 Mn
Jun 30, 2022 18.32 Mn
Mar 31, 2022 19.59 Mn
Dec 31, 2021 17.45 Mn
Sep 30, 2021 11.53 Mn